SAR288 has emerged as a potential therapeutic target for COVID-19. This pharmaceutical agent exhibits remarkable antiviral effects against SARS-CoV-2, the virus responsible for COVID-19. Preclinical studies have https://brianxdiw227776.blogdigy.com/a-novel-therapeutic-target-for-covid-19-59761314